Constellation Brands Inc (STZ)

Corona maker Constellation Brands tops forecasts as beer business drives earnings growthJuly 1, 2026 7:09 AM
IH Market News Strong beer performance lifts quarterly results Constellation Brands Inc Class A (NYSE:STZ) reported first-quarter results ahead of Wall Street expectations, supported by continued strength in its beer division. Adjusted earnings came in at $3.43 per share, surpassing the consensus forecast of $3.25 by $0.18. Revenue reached $2.43 billion, slightly above analysts’ expectations of $2.41 billion, although total sales declined 3% compared with the same period a year earlier. Shares rose 2.4% in premarket trading on Wednesday following the results. Beer segment offsets weakness elsewhere The company’s beer business remained its primary growth engine, with net sales increasing 2% to $2.28 billion and operating income also rising 2% to $891.4 million. Beer shipment volumes grew 1.8%, while Constellation continued to gain the largest dollar share among beer brands across tracked US retail channels. Within the wine and spirits division, organic net sales increased 8%. However, reported net sales fell 47% following the divestiture of several wine brands completed in 2025. Analysts highlight broad earnings beat Barclays analysts described the quarterly performance as stronger than anticipated despite softer expectations for the beer business in recent weeks. “STZ just reported a better-than-expected quarter across all key metrics, albeit in the context of estimates for the beer division that had moderated in recent weeks given weak industry scanner data,” the bank said in a post-results note. “The majority of the beat stemmed from better topline and margins, but we estimate a ~4c tailwind from BTL items (namely tax),” Barclays added. Company maintains full-year guidance Constellation reaffirmed its fiscal 2027 adjusted earnings guidance of between $11.20 and $11.90 per share. The midpoint of $11.55 remains below analysts’ consensus estimate of $11.74. The company continues to forecast enterprise organic net sales growth of between negative 1% and positive 1%, alongside free cash flow of $1.6 billion to $1.7 billion. Performance across the beer portfolio was mixed. Modelo Especial recorded an approximate 2% decline in depletion volumes, while Corona Extra fell by more than 5%. In contrast, Pacifico, Victoria and Modelo Chelada delivered growth of 21%, 14% and 6%, respectively. Operating cash flow increased 4% to $662 million, while free cash flow rose 9% to $485 million. “Our portfolio continues to benefit from the strength of our brands, disciplined commercial execution, and our ability to connect with consumers across a broad range of occasions,” said President and Chief Executive Officer Nicholas Fink. During the quarter, Constellation returned more than $400 million to shareholders through $324 million of share repurchases and dividend payments. Constellation Brands stock priceThe post Corona maker Constellation Brands tops forecasts as beer business drives earnings growth appeared first on US Editors. Original: Corona maker Constellation Brands tops forecasts as beer business drives earnings growth

NYSE Content Update: DDN's Kevin Delane Sets Sights on Scaling AI LeadershipMay 5, 2026 8:55 AM
PR Newswire (US) NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on May 5thEquities are fractionally higher as investors closely monitor new developments in the Middle East.NYSE-listed Circle, a component of the Global X NYSE 100 ETF, jumped by nearly 20% on Monday after lawmakers reached a compromise on the CLARITY Act.DDN's newly-minted President and CRO Kevin Delane will join NYSE Live to discuss how the company is establishing itself as a leader in AI data intelligence.Voyager Technologies Chairman and CEO Dylan Taylor will join Taking Stock to elaborate on what's fueling momentum following his company's Q1 earnings.For market insights, IPO activity, and today's opening bell, download the NYSE TV app at tv.nyse.comOpening Bell
Chesapeake Utilities Corporation (NYSE: CPK) celebrates Beth Cooper, Chief Financial Officer, as she retires following 36 years of dedicated service, including 18 years as CFOClosing Bell
Constellation Brands (NYSE: STZ) celebrates Cinco de MayoClick here to download the NYSE TV App View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-ddns-kevin-delane-sets-sights-on-scaling-ai-leadership-302762674.htmlSOURCE New York Stock Exchange Original: NYSE Content Update: DDN's Kevin Delane Sets Sights on Scaling AI Leadership

Constellation Brands’ FY27 profit outlook falls short of expectations, shares dipApril 9, 2026 7:14 AM
IH Market News
Constellation Brands Inc Class A (NYSE:STZ) projected fiscal 2027 earnings below analyst forecasts on Wednesday, warning that an uncertain macroeconomic backdrop could weigh on performance.The company’s shares slipped about 1.2% in premarket trading on Thursday following the announcement.Constellation said it expects comparable earnings per share for fiscal 2027 to range between $11.20 and $11.90, falling short of Wall Street’s consensus estimate of $12.44 per share.“As we look ahead to fiscal 2027, we expect consumers will continue to navigate a shifting macroeconomic environment, but we remain encouraged by the momentum we saw in the fourth quarter,” said Bill Newlands, President & CEO at Constellation Brands, who is scheduled to retire next week.Morgan Stanley analyst Dara Mohsenian described the company’s outlook as “seemingly conservative.”“The stock will probably give up some of its recent relative outperformance given below consensus FY27 guidance,” he added.Separately, analysts at Bank of America reaffirmed their Underperform rating on the stock, saying they “expect a negative reaction in shares.”Despite the cautious outlook, Constellation Brands reported stronger-than-expected fourth-quarter sales, supported by steady demand for its beer portfolio, including the Corona brand.Net sales for the quarter ended Feb. 28 declined 11% to $1.92 billion but still exceeded analyst expectations of $1.84 billion. The company said beer segment net sales rose more than 1% compared with the same period a year earlier, driven by shipment growth of 1.1% and favorable pricing, though partially offset by an unfavorable product mix.Fourth-quarter earnings per share came in at $1.90, representing a smaller decline than analysts had anticipated. Market expectations had called for earnings of $1.68 per share for the quarter.Earlier this year, the company also announced a leadership transition. In February, Constellation Brands said its board had appointed Nicholas Fink as the next President and Chief Executive Officer, effective April 13, 2026. Fink, who has served on the company’s board since 2021, will succeed Bill Newlands, who will step down as CEO but remain a member of the board of directors.Constellation Brands stock price

Original: Constellation Brands’ FY27 profit outlook falls short of expectations, shares dip

Looking for this to hold above $155, before starting position.

Tilray Brands' Bullish Beverage Strategy: What's Behind the Optimism?
https://finance.yahoo.com/news/tilray-brands-bullish-beverage-strategy-140500883.html $STZ $TLRY

$STZ Core Dependence on Alcohol Constellation’s portfolio is dominated by beer, wine, and spirits (Corona, Modelo, Robert Mondavi, Svedka). As awareness of alcohol’s toxic effects grows, this reliance becomes a structural vulnerability.

Health Risks of Products Alcohol is directly linked to liver disease, cancer, heart problems, and neurological damage. As public health campaigns intensify, demand for alcoholic beverages could decline.

Regulatory Pressure Governments worldwide are imposing higher taxes, stricter advertising rules, and mandatory warning labels on alcohol. These measures cut into margins and reduce consumption.

Shifting Consumer Preferences Younger generations are drinking less alcohol, turning toward non-alcoholic beverages, wellness products, and cannabis alternatives. Constellation risks losing relevance if it doesn’t adapt quickly.

Reputational Challenges Alcohol contributes to accidents, violence, and lost productivity. Companies profiting from these harms face reputational risks similar to those tobacco firms experienced.

ESG Investor Concerns Many investors focused on environmental, social, and governance (ESG) criteria avoid alcohol stocks, limiting capital inflows and potentially depressing valuations.

Litigation Risk Alcohol companies face potential lawsuits over health damages, drunk driving, or marketing practices — risks that could escalate as awareness grows.

Economic Sensitivity Premiumization strategies may falter if consumers cut back on discretionary spending, especially as health-conscious choices rise.

Long-Term Decline Risk Just as tobacco companies faced decades of decline after health risks became undeniable, alcohol producers like Constellation could see shrinking demand and mounting regulation over time.

⚖️ The Big Picture
Constellation Brands is a global powerhouse in beer, wine, and spirits, but its dependence on alcohol sales exposes it to health-driven consumer shifts, regulatory crackdowns, and reputational challenges. The very product that fuels its profits is also the source of long-term bearish pressure.

Constellation Brands sits at the intersection of consumer demand, cultural tradition, and health risk. On one hand, it’s a highly profitable company with iconic brands and strong growth prospects. On the other, its core business revolves around selling a product that is scientifically proven to cause disease.

This duality is what makes STZ both a compelling stock for investors and a complex company from a public health perspective. $STZ

https://finance.yahoo.com/news/tilray-brands-inc-tlry-among-034930975.html $STZ

$STZ Total Debt (mrq) $12.16B

STZ 10Q expected July 3

Let’s go STZ. Just buy CGC. You can do it. Cheers.

Great interview last night. Crammer. CGC.

CGC takeover. Rock and roll. Cheers

Breaking news. CGC. To be bought. Cheers.

STZ to buy CGC. News. Coming. Let’s go.

Constellation Brands Inc NYSE: STZ

GoSymbol lookup
Consumer Staples : Beverages

| Large Cap BlendCompany profile
Constellation Brands, Inc. is an international beverage and alcohol company. The Company is a producer and marketer of beer, wine, and spirits with operations in the United States, Mexico, New Zealand, and Italy. Its segments include Beer, Wine and Spirits, and Canopy. It sells a number of brands in the import and craft beer categories, including Corona Extra, Corona Light, Modelo Especial, Corona Premier, Victoria, Pacifico, and others. It offers a portfolio of wine and spirits brands, which include Cook’s California Champagne, Mount Veeder, My Favorite Neighbor, Casa Noble, Mi CAMPO, Kim Crawford, Ruffino, Robert Mondavi Winery, Copper & Kings, and others. The Canopy Equity Method Investment makes up the Canopy segment. It operates over five distilleries in the United States for the production of its spirits; two facilities for High West whiskey, one facility each for Copper & Kings American brandies, Nelson’s Green Brier bourbon and whiskey products, and Austin Cocktails.
New 52 week high

That target destination didn’t workout too well …

Is CGC. On the radar as a buyout. I say yes. Should be soon. Have great day. Cheers.

Surprised with how quiet it is here. Echo.......

Will this make new highs?

Okay so - How's about this guess ?.....Was it RIGHT ?
It was right COMPLETELY...ha


In fact, why it even predicted this whole thing (the Canopy weed / supreme stock merger)
4 sessions before it was announced.



Their board has always been a joke......
An absolute total, useless joke.....That's why I don't post there much.




Not much any more because.....



People they don't LIKE my posts - They think I'm kinda blunt however,




Count back 4 sessions - That's when the top chart was drawn.

I just remember....



http://ih.advfn.com/stock-market/NYSE/constellation-brands-STZ/stock-news/84298745/constellation-brands-on-pace-for-record-high-close

What? I have no idea what you said. Regardless, I made more than a couple hundred thousand dollars in 4-5 months. Chart on brother. I will stick with fundamentals - haha

Yeah well perhaps and but, yer not at all putting up any good charts and also, all
I was doing was correcting your....."expectations" :

Which as one can see, turned out HORRIBLY wrong.....




Why I doubt that you're even in fact, noticing THIS (or are at least just barely)




Anyways,

So, really I've just been wasting my time in supplying such excellent professional chart-work.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158304883

I still have my 1900 shares!

Interesting. I bought physical gold last summer. Old double eagles that were xf and got them at melt down price. Approx $1250. Only got 19 of them, but I am happy - and agree with your precious metals call.

This from last September here



That target destination is when and where Covid-19 struck





Just so much is reliant upon this HERE

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158298779






For example - Constellation's perfectly mimicking the S&P's afternoon down-draft today

I guess you still follow STZ - I got back in a little while after you called the bottom at about $105. Correct me if I am wrong, but you do not really forecast based on fundamentals. But you have to agree, the quarterly profit and revenue of STZ was nice. Where do your charts show STZ going in the future. Thank you. 1900 shares is what I hold.

Constellation Brands (STZ) – The maker of Corona and other beer and spirit brands reported quarterly earnings of $2.06 per share, beating the consensus estimate of $1.65 a share. Revenue also came in above forecasts. The company is not providing any full-year guidance due to the COVID-19 pandemic.

STZ's investment in Canopy seems to be on the right track - good quarter for Canopy - also the new management imposed on Canopy is doing its job well - today we have great chances for the stock to reach $ 175

Reporting for CGC - Q2 tomorrow

Watch the stock today - I think it will add $ 3-4

178 - 180 is an achievable target

$STZ | #ConstellationBrands Price Targets



A break above the 200ma on the daily could result
in a nice rally on the back of good earnings .
Local trendline resistance @ $186
Multiyear downtrend resistance @ approx $196
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

Oh 0 Okay - An after-the"fact" claim eh ?.....(LOVE those things)


Anyways, even if true - it seems you have overlooked the/my point

Oh I sold my 2500 shares on February 21 for $204.30 ... nice try though

Man.....For a guy who used to deal me a whole lot of flak...........

You sure turned out a whole lot WRONG





I was trying to HELP you.

The coronavirus is hammering everyone with every new announced case and death. Companies are cancelling meetings and going virtual. Airlines are getting hammered. The unintended consequences of trying to stem the spread of the virus is going to be devastating to earnings all around.

CGC, shuttering cultivation facilities should be considered a "wake-up" moment for another big LP that's going to put them on a clearer path towards profitability.

Give credit to new top mgmt and BoD members for taking action.

Wild huh ?- Oversupply ?.....Now who'd'a done thunk that ?

Ramifications ?.....Wonder how Sector'll perform next few days.

Boy.

Canopy Growth confirms closures, taking $700M-plus charges

Mar. 4, 2020 5:33 PM ET|About: Canopy Growth Corporation (CGC)|By: Jason Aycock, SA News Editor

I wonder how Constellation Brands feels about this? - FUNMAN

Canopy Growth (NYSE:CGC) has confirmed the shutdown of two greenhouses, a move it says it's making to align capacity with projected demand.

Shares are down 1.1% in postmarket NYSE trading.

Canopy will close the Aldergrove and Delta facilities as reported, a move that will result in eliminating 500 jobs. It's also shelving a plan to build a third greenhouse in Niagara-on-the-Lake, Ontario.

It will take estimated pretax charges of $700M-$800M in Q4 (the current quarter ending March 31), reflecting the closures as well as other changes from its organizational and strategic review.

Sales have fallen sharply.......

The Worlds' Greatest WEED Corp.....





Asked a certain poster here this question YEARS ago : Because they had just piled into them at $225 !.....

No Beer?, Legal Weed is Here: Beer Sales Decline

Read article here

HUge Guidance raise.

Great numbers !

News: $STZ Solid Dividend Investments in Alcohol Stocks

Alcoholic beverages might not be where most income investors turn to find dynamic dividend stocks , and after Anheuser-Busch InBev (NYSE: BUD) slashed its payout in half last year, you'd be forgiven for being wary of the space. Yet the sector tends to offer investors consistent payouts, an...

Find out more STZ - Solid Dividend Investments in Alcohol Stocks

News: $STZ Is Aurora Cannabis Stock on the Verge of Collapse?

Aurora Cannabis (NYSE: ACB) is one of the most popular marijuana stocks in the market today. Yet one analyst is not a fan of the Canadian cannabis producer. Earlier this week, GLJ Research analyst Gordon Johnson placed a sell rating on Aurora Cannabis' shares. Johnson also took ...

Read the whole news STZ - Is Aurora Cannabis Stock on the Verge of Collapse?

News: $STZ Weekly Cannabis Stock News: Illinois Pot Scofflaws Get a Big Break

Last week, the marijuana industry was in preparation mode. That's because it was in front of the latest big development in the sector, Cannabis 2.0. This initiative, which sanctions the sale of derivatives such as candies and non-alcoholic beverages in Canada, is going to start in earnest in the...

Read the whole news STZ - Weekly Cannabis Stock News: Illinois Pot Scofflaws Get a Big Break